RichardAlanNathanDO

Infectious Disease • Idaho Falls, ID

Assistant Professor of Infectious Disease, ICOM

Join to view full profile

Dr. Nathan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Nathan's full profile

Already have an account?

Office
3614 Washington Parkway
Idaho Falls, ID 83404
Phone+1 208-535-8400

Fax+1 208-535-8409
Is this information wrong?

Summary

Dr. Richard Nathan is an infectious disease specialist in Idaho Falls, ID and is affiliated with multiple hospitals in the area, including Mountain View Hospital, Portneuf Medical Center, and Bingham Memorial Hospital. He received his medical degree from NYIT College Of Osteopathic Medicine and has been in practice 25 years. He is experienced in bloodstream and transplant site infections.

Education & Training

Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Infectious Disease, 1996 - 1998
Yale-New Haven Medical CenterResidency, Internal Medicine, 1995 - 1996
Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Internal Medicine, 1993 - 1995
One Brooklyn Health SystemInternship, Transitional Year, 1992 - 1993
NYIT College Of Osteopathic MedicineClass of 1992

Certifications & Licensure

ID State License 2002 - 2025
NY State License 1994 - 2004
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013

Clinical Trials

SER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI) Start of enrollment: 2015 May 01
Completed
Phase 2
Phase 2 Safety and Efficacy Study of Daptomycin in Complicated Skin and Skin Structure Infections Start of enrollment: 2007 Jan 01
Completed
Phase 2
An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection Start of enrollment: 2019 Aug 02
Recruiting
Phase 2
Ultramicronized Palmitoylethanolamide (PEA) Treatment in Hospitalized Participants With COVID-19 Start of enrollment: 2020 Dec 14
Terminated
Phase 2
Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects Start of enrollment: 2021 May 19
Terminated
Phase 3
COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis Start of enrollment: 2021 Feb 15
Completed
Phase 3
Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection Start of enrollment: 2021 Jan 05
Active, not recruiting
Phase 2
A Phase 1/2 Study to Assess Safety and Efficacy of BAT2020 in Hospitalized COVID-19 Patients Start of enrollment: 2020 Oct 20
Withdrawn
Phase 1, Phase 2
Evaluation of the Safety and Efficacy of Razuprotafib in Hospitalized Subjects With Coronavirus Disease 2019 Start of enrollment: 2020 Oct 21
Terminated
Phase 2
A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications Start of enrollment: 2018 Jan 21
Terminated
Phase 3
Study to Assess Safety, Tolerability and Efficacy of Incremental Doses of MGB-BP-3 in Patients With CDAD Start of enrollment: 2019 Feb 07
Completed
Phase 2
Comparison of Cadazolid Versus Vancomycin in Children With Clostridium Difficile-associated Diarrhea (CDAD) Start of enrollment: 2017 Apr 14
Terminated
Phase 2, Phase 3
SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence Start of enrollment: 2016 Aug 01
Completed
Phase 1
Effect of Exeporfinium Chloride (XF-73) Gel on Nasal S.Aureus in Patients at Risk of Post-op Staphylococcal Infection Start of enrollment: 2019 Aug 29
Completed
Phase 2
Study of the Clinical Effectiveness of a Human Monoclonal Antibody to C. Difficile Toxin A and Toxin B in Patients With Clostridium Difficile Associated Disease Start of enrollment: 2006 Jul 20
Completed
Phase 2
West Nile Virus Natural History Start of enrollment: 2003 Sep 01
Completed
Comparative Study of NXL103 Versus Linezolid in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Start of enrollment: 2009 Nov 01
Completed
Phase 2
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections Start of enrollment: 2007 Mar 08
Completed
Phase 3
Study of CB-183,315 in Participants With Clostridium Difficile Infection Start of enrollment: 2010 Apr 01
Completed
Phase 2
IVIG - West Nile Encephalitis: Safety and Efficacy Start of enrollment: 2003 Sep 01
Completed
Phase 1, Phase 2
Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci Start of enrollment: 2007 Jun 26
Completed
Phase 2
Safety and Immunogenicity Study of ChimeriVax West Nile Vaccine in Healthy Adults Start of enrollment: 2008 Oct 01
Completed
Phase 2
A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza Start of enrollment: 2008 Jul 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensu...
Matthew Greenhawt, Timothy E Dribin, Elissa M Abrams, Marcus Shaker, Derek K Chu, David B K Golden, Cem Akin, Akterini Anagnostou, Faisal ALMuhizi, Waleed Alqurashi, P...> ;The Journal of Allergy and Clinical Immunology. 2023 Aug 1
532 citations
Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults
Abstr Act, Carlos A. DiazGranados, Andrew J. Dunning, Murray A Kimmel, John J. Treanor, Avi Collins, Richard Pollak, Janet Christoff, John Earl, Victoria Landolfi, Ear...> ;The New England Journal of Medicine. 2014 Aug 13
7 citations
Exploratory evaluation of bezlotoxumab on outcomes associated with Clostridioides difficile infection in MODIFY I/II participants with cancer
Oliver A. Cornely, Kathleen M. Mullane, Thomas Birch, Sabine Hazan-Steinberg, Richard Nathan, Emilio Bouza, David P. Calfee, Misoo C. Ellison, Michael T Wong, Mary Bet...> ;Open Forum Infectious Diseases. 2020 Jan 31
73 citations
Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controll...
Richard Vickers, Glenn S. Tillotson, Richard Nathan, Sabine Hazan, John Pullman, Christopher Lucasti, Kenneth Deck, Bruce R. Yacyshyn, Benedict Maliakkal, Yves Pesant,...> ;The Lancet. Infectious Diseases. 2017 Jul 1
436 citations
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
Mark H. Wilcox, Dale N. Gerding, Ian R. Poxton, Ciaran P. Kelly, Richard Nathan, Thomas Birch, Oliver A. Cornely, Galia Rahav, Emilio Bouza, Christine H. Lee, Grant Je...> ;The New England Journal of Medicine. 2017 Jan 25
75 citations
Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial.
Guy de Bruyn, Jamshid Saleh, David Workman, Richard Pollak, Victor Elinoff, Neil J Fraser, Gigi Lefebvre, Mark G. Martens, Richard E Mills, Richard P. Nathan, Miguel T...> ;Vaccine. 2016 Apr 27
23 citations
A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections
Peter Matthews, Marc Alpert, Galia Rahav, Denise Rill, Edward T. Zito, David Gardiner, Ron Pedersen, Timothy Babinchak, Paul C. McGovern, Peter Armstrong, Charles L. B...> ;BMC Infectious Diseases. 2012 Nov 12
6 citations
Extremely low excretion of daptomycin into breast milk of a nursing mother with methicillin-resistant Staphylococcus aureus pelvic inflammatory disease.
Martha I Buitrago, Jason A. Crompton, Shellie Bertolami, Donald S. North, Richard A Nathan> ;Pharmacotherapy. 2009 Mar 1
Join now to see all

Press Mentions

How Crisis Standards of Care Impacts Eastern Idaho HospitalsSeptember 16th, 2021
Most Nursing Home Workers Unvaccinated in Idaho, New Data ShowJune 19th, 2021
Idaho Won't Disclose Vaccination Rates in Long-Term Care FacilitiesMay 17th, 2021
Join now to see all